STAA
Staar SurgicalยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
STAA Profile
Staar Surgical Company
A developer of implantable lenses for the eye and companion delivery systems
Healthcare Equipment and Supplies
--
10/26/1990
NASDAQ Stock Exchange
1,157
12-31
Common stock
25510 Commercentre Drive, Lake Forest, California 92630
--
Staar Surgical Company designs, develops, manufactures and sells implantable lenses. The company is the world's leading manufacturer of lenses used in corrective or "refractive" surgery, and its lenses are also used to treat cataract surgery. All of the company's lenses are foldable, allowing surgeons to insert them through a small incision during minimally invasive surgery. Refractive surgery corrects visual impairment, the traditional treatment of visual impairment such as glasses or contact lenses. The company refers to the lenses used in refractive surgery as "implantable intraocular contact lenses" or "intraocular lens implantation. ". The field of refractive surgery includes lens-based procedures using products such as ICL and laser-based procedures such as LASIK surgery. Successful refractive surgery can correct common vision disorders such as nearsightedness, farsightedness and astigmatism. STAAR Surgical was originally incorporated in California in 1982 and re-merged in Delaware in 1986.
